Intellia Therapeutics NTLA Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Intellia Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Intellia Therapeutics's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Intellia Therapeutics's current ratio?
- Intellia Therapeutics (NTLA) reported current ratio of 6.1× in Q1 2026.
- How has Intellia Therapeutics's current ratio changed year-over-year?
- Intellia Therapeutics's current ratio increased by 24.6% year-over-year, from 4.9× to 6.1×.
- What is the long-term trend for Intellia Therapeutics's current ratio?
- Over 5 years (2020 to 2025), Intellia Therapeutics's current ratio has grown at a -11.9% compound annual growth rate (CAGR), from 9.6× to 5.1×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.